Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.85 |
| ▸ | MAOA | P21397 | 4/20 | 0.46 |
| ▸ | ACHE | P22303 | 5/20 | 0.42 |
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29565284 | 1.00 | MAOB (0.85) | MAOBMAOAACHEBCHEKDM4E | |
| SCHEMBL31231150 | 0.92 | MAOB (1.00) | MAOBMAOAACHEBCHEKDM4E | |
| SCHEMBL30311 | 0.92 | MAOB (1.00) | MAOBMAOAACHEBCHEKDM4E | |
| SCHEMBL8530667 | 0.90 | MAOB (0.96) | MAOBMAOAACHEBCHEKDM4E | |
| Bromide SCHEMBL1821620 | 0.90 | MAOB (0.96) | MAOBMAOAACHEBCHEKDM4E | |
| Sulfuric Acid SCHEMBL141163 | 0.81 | MAOB (0.77) | MAOBMAOAACHEBCHEKDM4E | |
| Acetic Acid SCHEMBL1819921 | 0.81 | MAOB (0.77) | MAOBMAOAACHEBCHEKDM4E | |
| Sulfuric Acid SCHEMBL141164 | 0.80 | MAOB (0.74) | MAOBMAOAACHEBCHEKDM4E | |
| SCHEMBL5691350 | 0.79 | MAOB (0.75) | MAOBMAOAACHEBCHEKDM4E | |
| SCHEMBL8008700 | 0.77 | MAOB (0.70) | MAOBMAOAACHEBCHEKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES A/S (DK) | 2026-05-14 | — | — | US | disclosed |
| EP-4717756-A2 | LIPASE VARIANTS AND DETERGENT COMPOSITIONS | Novozymes A/S (DK) | 2026-04-01 | — | — | EP | disclosed |
| US-12559736-B2 | Lipase variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2026-02-24 | — | — | US | disclosed |
| US-12529017-B2 | Detergent composition comprising a lipase | NOVOZYMES A/S (DK) | 2026-01-20 | — | — | US | disclosed |
| US-20250382594-A1 | METHODS OF REDUCING ODOR | NOVOZYMES A/S (DK) | 2025-12-18 | — | — | US | disclosed |
| US-12492387-B2 | Lipase variants and microcapsule compositions comprising such lipase variants | NOVOZYMES A/S (DK) | 2025-12-09 | — | — | US | disclosed |
| US-20250368924-A1 | LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES A/S (DK) | 2025-12-04 | — | — | US | disclosed |
| US-12480108-B2 | Methods of reducing odor | Novozyms A/S (DK) | 2025-11-25 | — | — | US | disclosed |
| US-12480107-B2 | Lipase variants and the use thereof | NOVOZYMES A/S (DK) | 2025-11-25 | — | — | US | disclosed |
| US-20250250514-A1 | COMPOSITION | KAO CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| US-20070173430-A1 | Composition comprising a lipase and a bleach catalyst | THE PROCTER & GAMBLE COMPANY | 2007-07-26 | — | — | US | disclosed |
| US-20070173429-A1 | Composition comprising a lipase and a bleach catalyst | THE PROCTER & GAMBLE COMPANY | 2007-07-26 | — | — | US | disclosed |
| WO-2007083276-A1 | A COMPOSITION COMPRISING A PRE-FORMED PEROXYACID AND A BLEACH CATALYST | THE PROCTER & GAMBLE COMPANY (US) | 2007-07-26 | — | — | WO | disclosed |
| EP-1811014-A1 | A composition comprising a pre-formed peroxyacid and a bleach catalyst | The Procter and Gamble Company (US) | 2007-07-25 | — | — | EP | disclosed |
| US-20070123441-A1 | Stable odorant systems | PROCTER & GAMBLE COMPANY, THE | 2007-05-31 | — | — | US | disclosed |
| WO-2007060645-A2 | STABLE ODORANT SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20070123440-A1 | Stable odorant systems | THE PROCTER & GAMBLE COMPANY | 2007-05-31 | — | — | US | disclosed |
| EP-1704217-A1 | ORGANIC CATALYST SYSTEM | The Procter and Gamble Company (US) | 2006-09-27 | — | — | EP | disclosed |
| WO-2005073360-A1 | ORGANIC CATALYST SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2005-08-11 | — | — | WO | disclosed |
| US-20050159327-A1 | Organic catalyst system | THE PROCTER & GAMBLE COMPANY | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559736-B2 | Lipase variants and polynucleotides encoding same | LPL, PNLIP, LIPG | MAOB 1080/4885MAOA 1184/4885ACHE 1010/4885 |
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | LIPE, LPL, PNLIP | MAOB 1197/4885MAOA 1909/4885ACHE 1054/4885 |
| US-12529017-B2 | Detergent composition comprising a lipase | MGLL, LPL, LIPC | MAOB 2721/4885MAOA 2245/4885ACHE 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.